Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study.
<h4>Background</h4>Although antiretroviral therapy (ART) improves survival in persons with cryptococcal meningitis (CM) and AIDS, ART frequently elicits HIV immune reconstitution inflammatory syndrome (IRIS), an exaggerated and frequently deadly inflammatory reaction that complicates rec...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2010
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/d6d6d8bbbf0c4c86884a277949b1adaf |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:d6d6d8bbbf0c4c86884a277949b1adaf |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:d6d6d8bbbf0c4c86884a277949b1adaf2021-11-18T05:41:58ZClinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study.1549-12771549-167610.1371/journal.pmed.1000384https://doaj.org/article/d6d6d8bbbf0c4c86884a277949b1adaf2010-12-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21253011/?tool=EBIhttps://doaj.org/toc/1549-1277https://doaj.org/toc/1549-1676<h4>Background</h4>Although antiretroviral therapy (ART) improves survival in persons with cryptococcal meningitis (CM) and AIDS, ART frequently elicits HIV immune reconstitution inflammatory syndrome (IRIS), an exaggerated and frequently deadly inflammatory reaction that complicates recovery from immunodeficiency. The pathogenesis of IRIS is poorly understood and prediction of IRIS is not possible.<h4>Methods and findings</h4>We prospectively followed 101 ART-naïve Ugandans with AIDS and recent CM for one year after initiating ART, and used Luminex multiplex assays to compare serum cytokine levels in participants who did or did not develop IRIS. IRIS occurred in 45% of participants with recent CM on ART, including 30% with central nervous system (CNS) manifestations. The median time to CM-IRIS was 8.8 wk on ART. Overall mortality on ART was 36% with IRIS and 21% without IRIS. CM-IRIS was independently associated with death (HR = 2.3, 95% CI 1.1-5.1, p = 0.04). Patients experiencing subsequent CM-IRIS had 4-fold higher median serum cryptococcal antigen (CRAG) levels pre-ART (p = 0.006). Higher pre-ART levels of interleukin (IL)-4 and IL-17 as well as lower tumor necrosis factor (TNF)-α, granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and vascular endothelial growth factor (VEGF) predicted future IRIS in multivariate analyses (area under the curve [AUC] = 0.82). An algorithm based on seven pre-ART serum biomarkers was a robust tool for stratifying high (83%), moderate (48%), and low risk (23%) for IRIS in the cohort. After ART was initiated, increasing levels of C-reactive protein (CRP), D-dimer, IL-6, IL-7, IL-13, G-CSF, or IL-1RA were associated with increasing hazard of IRIS by time-to-event analysis (each p≤0.001). At the time of IRIS onset, multiple proinflammatory cytokine responses were present, including CRP and IL-6. Mortality was predicted by pre-ART increasing IL-17, decreasing GM-CSF, and CRP level >32 mg/l (highest quartile). Pre-ART CRP level >32 mg/l alone was associated with future death (OR = 8.3, 95% CI 2.7-25.6, p<0.001).<h4>Conclusions</h4>Pre-ART increases in Th(17) and Th(2) responses (e.g., IL-17, IL-4) and lack of proinflammatory cytokine responses (e.g., TNF-α, G-CSF, GM-CSF, VEGF) predispose individuals to subsequent IRIS, perhaps as biomarkers of immune dysfunction and poor initial clearance of CRAG. Although requiring validation, these biomarkers might be an objective tool to stratify the risk of CM-IRIS and death, and could be used clinically to guide when to start ART or use prophylactic interventions.David R BoulwareDavid B MeyaTracy L BergemannDarin L WiesnerJoshua RheinAbdu MusubireSarah J LeeAndrew KambuguEdward N JanoffPaul R BohjanenPublic Library of Science (PLoS)articleMedicineRENPLoS Medicine, Vol 7, Iss 12, p e1000384 (2010) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R |
| spellingShingle |
Medicine R David R Boulware David B Meya Tracy L Bergemann Darin L Wiesner Joshua Rhein Abdu Musubire Sarah J Lee Andrew Kambugu Edward N Janoff Paul R Bohjanen Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study. |
| description |
<h4>Background</h4>Although antiretroviral therapy (ART) improves survival in persons with cryptococcal meningitis (CM) and AIDS, ART frequently elicits HIV immune reconstitution inflammatory syndrome (IRIS), an exaggerated and frequently deadly inflammatory reaction that complicates recovery from immunodeficiency. The pathogenesis of IRIS is poorly understood and prediction of IRIS is not possible.<h4>Methods and findings</h4>We prospectively followed 101 ART-naïve Ugandans with AIDS and recent CM for one year after initiating ART, and used Luminex multiplex assays to compare serum cytokine levels in participants who did or did not develop IRIS. IRIS occurred in 45% of participants with recent CM on ART, including 30% with central nervous system (CNS) manifestations. The median time to CM-IRIS was 8.8 wk on ART. Overall mortality on ART was 36% with IRIS and 21% without IRIS. CM-IRIS was independently associated with death (HR = 2.3, 95% CI 1.1-5.1, p = 0.04). Patients experiencing subsequent CM-IRIS had 4-fold higher median serum cryptococcal antigen (CRAG) levels pre-ART (p = 0.006). Higher pre-ART levels of interleukin (IL)-4 and IL-17 as well as lower tumor necrosis factor (TNF)-α, granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and vascular endothelial growth factor (VEGF) predicted future IRIS in multivariate analyses (area under the curve [AUC] = 0.82). An algorithm based on seven pre-ART serum biomarkers was a robust tool for stratifying high (83%), moderate (48%), and low risk (23%) for IRIS in the cohort. After ART was initiated, increasing levels of C-reactive protein (CRP), D-dimer, IL-6, IL-7, IL-13, G-CSF, or IL-1RA were associated with increasing hazard of IRIS by time-to-event analysis (each p≤0.001). At the time of IRIS onset, multiple proinflammatory cytokine responses were present, including CRP and IL-6. Mortality was predicted by pre-ART increasing IL-17, decreasing GM-CSF, and CRP level >32 mg/l (highest quartile). Pre-ART CRP level >32 mg/l alone was associated with future death (OR = 8.3, 95% CI 2.7-25.6, p<0.001).<h4>Conclusions</h4>Pre-ART increases in Th(17) and Th(2) responses (e.g., IL-17, IL-4) and lack of proinflammatory cytokine responses (e.g., TNF-α, G-CSF, GM-CSF, VEGF) predispose individuals to subsequent IRIS, perhaps as biomarkers of immune dysfunction and poor initial clearance of CRAG. Although requiring validation, these biomarkers might be an objective tool to stratify the risk of CM-IRIS and death, and could be used clinically to guide when to start ART or use prophylactic interventions. |
| format |
article |
| author |
David R Boulware David B Meya Tracy L Bergemann Darin L Wiesner Joshua Rhein Abdu Musubire Sarah J Lee Andrew Kambugu Edward N Janoff Paul R Bohjanen |
| author_facet |
David R Boulware David B Meya Tracy L Bergemann Darin L Wiesner Joshua Rhein Abdu Musubire Sarah J Lee Andrew Kambugu Edward N Janoff Paul R Bohjanen |
| author_sort |
David R Boulware |
| title |
Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study. |
| title_short |
Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study. |
| title_full |
Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study. |
| title_fullStr |
Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study. |
| title_full_unstemmed |
Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study. |
| title_sort |
clinical features and serum biomarkers in hiv immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2010 |
| url |
https://doaj.org/article/d6d6d8bbbf0c4c86884a277949b1adaf |
| work_keys_str_mv |
AT davidrboulware clinicalfeaturesandserumbiomarkersinhivimmunereconstitutioninflammatorysyndromeaftercryptococcalmeningitisaprospectivecohortstudy AT davidbmeya clinicalfeaturesandserumbiomarkersinhivimmunereconstitutioninflammatorysyndromeaftercryptococcalmeningitisaprospectivecohortstudy AT tracylbergemann clinicalfeaturesandserumbiomarkersinhivimmunereconstitutioninflammatorysyndromeaftercryptococcalmeningitisaprospectivecohortstudy AT darinlwiesner clinicalfeaturesandserumbiomarkersinhivimmunereconstitutioninflammatorysyndromeaftercryptococcalmeningitisaprospectivecohortstudy AT joshuarhein clinicalfeaturesandserumbiomarkersinhivimmunereconstitutioninflammatorysyndromeaftercryptococcalmeningitisaprospectivecohortstudy AT abdumusubire clinicalfeaturesandserumbiomarkersinhivimmunereconstitutioninflammatorysyndromeaftercryptococcalmeningitisaprospectivecohortstudy AT sarahjlee clinicalfeaturesandserumbiomarkersinhivimmunereconstitutioninflammatorysyndromeaftercryptococcalmeningitisaprospectivecohortstudy AT andrewkambugu clinicalfeaturesandserumbiomarkersinhivimmunereconstitutioninflammatorysyndromeaftercryptococcalmeningitisaprospectivecohortstudy AT edwardnjanoff clinicalfeaturesandserumbiomarkersinhivimmunereconstitutioninflammatorysyndromeaftercryptococcalmeningitisaprospectivecohortstudy AT paulrbohjanen clinicalfeaturesandserumbiomarkersinhivimmunereconstitutioninflammatorysyndromeaftercryptococcalmeningitisaprospectivecohortstudy |
| _version_ |
1718424882209882112 |